Suppr超能文献

[尤因肉瘤的放射治疗:德国儿科肿瘤学会CESS 81和CESS 86研究的当前结果]

[Radiotherapy in Ewing sarcoma: current results of the German Society of Pediatric Oncology studies CESS 81 and CESS 86].

作者信息

Dunst J, Sauer R, Burgers J M, Hawliczek R, Kürten R, Müller R P, Wannenmacher M, Jürgens H

机构信息

Strahlentherapeutische Klinik der Universität Erlangen-Nürnberg.

出版信息

Klin Padiatr. 1988 May-Jun;200(3):261-6. doi: 10.1055/s-2008-1033718.

Abstract

In CESS 81 the rate of local recurrences was high particularly in patients with radiation for local control. To improve the safety of local control, in the follow-up study CESS 86 chemotherapy for high risk patients was intensified. The combination of surgery with postoperative radiation was favoured when possible, local control was brought forward from week 18 to week 9, the doses of postoperative radiotherapy was increased from 36 to 46 Gy, and a radiation planning center was established for centralized planning of radiotherapy on the basis of tumor extension at diagnosis. In addition patients with radiation were randomized for conventional fractionation or a scheme of accelerated split course hyperfractionation with simultaneous chemotherapy. Preliminary results of 76 CESS 86 patients (incl. pilot phase), show a lowered rate of local recurrences compared to CESS 81: 6% local recurrences and 15% local recurrences in patients with radiation. With selection of patients with small and chemoresponsive tumors for radiotherapy no longer a disadvantage was seen for patients with radiotherapy concerning the safety of local control.

摘要

在CESS 81研究中,局部复发率较高,尤其是在接受放疗以进行局部控制的患者中。为提高局部控制的安全性,在后续的CESS 86研究中,对高危患者强化了化疗。尽可能采用手术联合术后放疗,局部控制时间从第18周提前至第9周,术后放疗剂量从36 Gy增加到46 Gy,并设立了放疗计划中心,以便根据诊断时肿瘤的扩展情况进行放疗的集中规划。此外,接受放疗的患者被随机分为常规分割或加速分割超分割联合同步化疗方案。76例CESS 86患者(包括试验阶段)的初步结果显示,与CESS 81相比,局部复发率降低:接受放疗的患者局部复发率分别为6%和15%。通过选择肿瘤较小且对化疗敏感的患者进行放疗,放疗患者在局部控制安全性方面不再处于劣势。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验